India Biopharmaceutical Market By Type Overview
Introduction:
India Biopharmaceutical Market is one of the fastest-growing biotechnology segments in India. A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. The significant biopharmaceutical clusters of India are located in Haridwar, Sikkim, Hyderabad, Vishakhapatnam, Chennai, Pondicherry, Mysore, Mumbai, Ahmedabad, and Delhi NCR.
Drivers and Restraints:
Highly skilled and experienced scientists who serve as a strong support system for the business process of the biopharmaceutical industry. With the help of the educational qualifications and skillset of these people, India is considered to be a significant centre for biopharmaceutical research and development (R&D), especially for vaccine manufacturing. The Government of India has approved an investment of INR 15,000 Mn under the Innovate in India program, for collaboration of industrial organizations and academic organizations over the next five years. This program is considered to act as a significant action of the Government in its way of boosting bio-pharmaceutical production in the country. However, it often takes a long time for the manufacturing companies to launch a new market-ready bio-pharmaceutical product in India due to the existence of numerous regulatory challenges in the process. Also, the Indian biopharmaceutical industry lacks proper infrastructure regarding limited government-sponsored laboratory space, consumables, chemical components, and equipment, which acts as a significant hindrance to the growth of the market.
Segmentation:
The India bio-pharmaceutical market is segmented based on type, and application.
Based on type, the India bio-pharmaceutical market is segmented into monoclonal antibody, interferon, insulin, growth & coagulation factor, erythropoietin, vaccine, hormone, and, others. Based on the application, the target market is segmented into oncology, a blood disorder, metabolic disease, infectious disease, cardiovascular disease, neurological disease, immunology, and others.
Key Players:
The key players operating the global India Biopharmaceutical market involve Biocon Ltd., Cadila Healthcare Ltd., Dr Reddy’s Laboratories Ltd., Panacea Biotec Ltd., Wockhardt Ltd., GSK Pharmaceuticals Ltd., Bharat Biotec International Ltd., and Bharat Serums and Vaccines Ltd. For instance, in February 2017, Cipla, Serum Institute launch Hepatitis B vaccine. Global CEO Umang Vohra said the agreement will enable Cipla to provide affordable vaccines for a chronic disease like Hepatitis B. Cipla's strong marketing network and reach will ensure maximum accessibility of the vaccines in India.
Detailed Segmentation
India Biopharmaceutical Market, By Type:
- Monoclonal Antibody
- Interferon
- Insulin
- Growth & Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others.
India Biopharmaceutical Market, By Application:
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Others.
Company Profile:
-
-
- Biocon Ltd.
- Company Overview
- Biocon Ltd.
-
-
-
-
- Product Portfolio
- Key Highlights
- Financial Performance
- Dr Reddy’s Laboratories Ltd.
- Cadila Healthcare Ltd.
- Panacea Biotec Ltd.
- Wockhardt Ltd.
- GSK Pharmaceuticals Ltd.
- Bharat Biotec International Ltd.
- Bharat Serums and Vaccines Ltd.
-
-
“*” marked represents similar segmentation in other categories in the respective section
India Biopharmaceutical Market By Type Table of Contents
Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Industry Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for India Biopharmaceutical Market Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Application
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- India Biopharmaceutical Market, By Type, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Monoclonal Antibody
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Interferon, Insulin
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Growth & Coagulation Factor
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Erythropoietin
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Vaccine
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Hormone
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- India Biopharmaceutical Market, By Application, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends (US$ Mn)
- Oncology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Blood Disorder
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Metabolic Disease
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Infectious Disease
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Cardiovascular Disease
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Neurological Disease
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Immunology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Biocon Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Tragedy
- Cadila Healthcare Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Tragedy
- Dr Reddy’s Laboratories Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Tragedy
- Panacea Biotec Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Tragedy
- Wockhardt Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Tragedy
- GSK Pharmaceuticals Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Tragedy
- Bharat Biotec International Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Tragedy
- Bharat Serums and Vaccines Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Tragedy
- Biocon Ltd.
-
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The India bio-pharmaceutical market is segmented based on type, and application.
the growth of biosimilars, the focus on innovative biopharmaceutical research, and advancements in manufacturing technologies, presenting significant opportunities in the India Biopharmaceutical Market.
increasing demand for biopharmaceuticals, a favorable regulatory environment, cost advantages in biopharmaceutical production, and the presence of a skilled workforce in India's pharmaceutical industry.
The report may primarily focus on India as a country-specific market. Domination within India is likely to be influenced by factors such as manufacturing capabilities, research and development activities, and market presence of key players within the country.
Dr Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Panacea Biotec Ltd., Wockhardt Ltd., GSK Pharmaceuticals Ltd., Bharat Biotec International Ltd., Bharat Serums and Vaccines Ltd.,